Neonatal and delivery outcomes in women with multiple sclerosis.

"Potential Conflicts of Interest H.T.: funding, MS Society of Canada (Don Paty Career Development Award); grants, CIHR US National MS Society, Martha Piper Research Fund, Public Health Agency of Canada, BC Clinical Genomics Network, Canada Research Chair program, Michael Smith Foundation for Health Research, MS Society of Canada, UK MS Trust; speaker honoraria and/or travel expenses, Consortium of MS Centres, US National MS Society, Swiss MS Society, University of BC MS Research Program, Bayer Pharmaceutical (honoraria declined), Teva Pharmaceutical, Serono Symposia International Foundation, MS Society of Canada, CIHR, MS Society of Iran; unless otherwise stated, all speaker honoraria were either donated to an MS charity or to an unrestricted grant for use by her research group. D.S.: research support, MS Society of Canada Scientific Research Foundation, CIHR; consultancy, Biogen-Idec, Bayer, Merck-Serono, Teva Neuroscience; grants/grants pending, CIHR, MS Society of Canada; speaking fees, Biogen-Idec, Bayer, Merck-Serono, Teva Neuroscience; manuscript preparation, MSAA; travel expenses, Biogen-Idec, Bayer, Merck-Serono, Teva Neuroscience. A.-L.S.: funding, MS Society of Canada (postdoctoral fellowship)."

"This work was supported by the Canadian Institutes of Health Research (CIHR; operating grant MOP-106607; principal investigator, H.T.). The BCMS database was funded by an unrestricted grant from Dr Donald Paty and the MS/MRI Research Group."